EUVIMEDEUVIMED entdecken
Crossref

Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C 6 Mab-19 with the High Binding Affinity in Flow Cytometry

Tomohiro Tanaka, Kaishi Kitamura, Hiroyuki Suzuki, Mika K Kaneko, Yukinari Kato iD

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2023

DOI: 10.1089/mab.2023.0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2023. Verfasst von Tomohiro Tanaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Chemokine CCL20, Antibodies, Monoclonal. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CC chemokine receptor 6 (CCR6) is a member of the G-protein-coupled receptor family that is highly expressed in B lymphocytes, effector and memory T cells, regulatory T cells, and immature dendritic cells. CCR6 has been revealed to have important functions in many pathological conditions, such as cancer, intestinal bowel disease, psoriasis, and autoimmune diseases. The only CCR6 chemokine ligand, CC motif chemokine ligand 20 (CCL20), is also involved in pathogenesis by interacting with CCR6. The CCL20/CCR6 axis is drawing attention as an attractive therapeutic target for various diseases. In this study, we developed novel monoclonal antibodies (mAbs) against human CCR6 (hCCR6) using the peptide immunization method, which are applicable to flow cytometry and immunohistochemistry. The established anti-hCCR6 mAb, clone C 6 Mab-19 (mouse IgG 1 , kappa), reacted with hCCR6-overexpressed Chinese hamster ovary-K1 (CHO/hCCR6), human liver carcinoma (HepG2), and human differentiated hepatoma (HuH-7) cells in flow cytometry. The dissociation constant ( K D ) of C 6 Mab-19 was determined as 3.0 × 10 −10 M for CHO/hCCR6, 6.9 × 10 −10 M for HepG2, and 1.8 × 10 −10 M for HuH-7. Thus, C 6 Mab-19 could bind to exogenously and endogenously expressed hCCR6 with extremely high affinity. Furthermore, C 6 Mab-19 could stain formalin-fixed paraffin-embedded lymph node tissues from a patient with non-Hodgkin lymphoma by immunohistochemistry. Therefore, C 6 Mab-19 is suitable for detecting hCCR6-expressing cells and tissues and could be useful for pathological analysis and diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CCL20Antibodies, MonoclonalHumansAnimalsMiceCricetinaeReceptors, CCR6Flow CytometryCHO CellsLigandsCricetulusChemokines, CC

Stichwörter der Autor:innen

CCR6flow cytometryimmunohistochemistrymonoclonal antibodypeptide immunization

Substanzen

Chemokine CCL20Antibodies, MonoclonalReceptors, CCR6LigandsChemokines, CCCCR6 protein, humanCCR6 protein, mouse

Autor:innen und Institutionen

  • Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID-Profile: Yukinari Kato

Zitieren

APA

Tanaka, T., Kitamura, K., Suzuki, H., Kaneko, M. K., & Kato, Y. (2023). Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C 6 Mab-19 with the High Binding Affinity in Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1089/mab.2023.0004

Vancouver

Tanaka T, Kitamura K, Suzuki H, Kaneko MK, Kato Y. Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C 6 Mab-19 with the High Binding Affinity in Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2023. doi:10.1089/mab.2023.0004

BibTeX
@article{Tanaka2023,
  author = {Tanaka, Tomohiro and Kitamura, Kaishi and Suzuki, Hiroyuki and Kaneko, Mika K and Kato, Yukinari},
  title = {Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C 6 Mab-19 with the High Binding Affinity in Flow Cytometry},
  journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
  year = {2023},
  doi = {10.1089/mab.2023.0004}
}
Kostenlos starten →